Find Academic Supervisors

• Cardiac Physiology
• Cardiovascular Metabolism
• Heart Failure
• +3 more

Craig Lygate is an Associate Professor of Cardiovascular Physiology at the University of Oxford's Division of Cardiovascular Medicine, leading the 'Cardiac Energetics and Integrative Physiology' research group funded by the British Heart Foundation. His work focuses on understanding cardiac energy metabolism's role in health and disease, particularly exploring therapies for ischaemia and heart failure. He heads the Murine Cardiac Phenotyping Laboratory, using clinical techniques like echocardiography and MRI to assess genetically modified models. Education includes a BSc (Hons), MRes in Biological Sciences (University of Manchester), and a PhD in Cardiovascular Physiology (University of Glasgow). His research combines biochemical assays, cell culture, and collaborative approaches such as genomics and metabolomics, with a current emphasis on the creatine transporter and homoarginine's therapeutic potential. Recent articles highlight advancements in nitric oxide delivery systems for cardiovascular applications and the creatine kinase system's role in cardiac energy provision. Collaborations with Chemistry departments target novel treatments for ischaemia-reperfusion injury. No scientific awards are explicitly listed, but his work has been published in high-impact journals like Circulation and Clinical Science . He advises postgraduate researchers (e.g., Hannah Lake) and oversees grants focused on cardiac energetics. His lab integrates translational research, bridging molecular biology with clinical applications, aiming to translate findings into therapeutic strategies for cardiovascular diseases.

Michael GeorgiadesView profile

Assistant Professor

• Computer Networks
• Tactile Internet
• Mobile Edge Computing
• +3 more

Dr. Michael Georgiades is an Assistant Professor at Neapolis University of Pafos, specializing in computer networks. He holds a BEng (First Class Honours) from King’s College London, an MSc from University College London, and a PhD from the University of Surrey. His career includes roles as R&D Manager at Primetel PLC, Research Fellow at the Centre of Communication Systems Research (CCSR), and Systems Development Engineer at INSIG Ltd. He has contributed to EU-funded ICT projects, holds patents, and authored IETF standards. His research focuses on Tactile Internet, Mobile Edge Computing, Vehicular Networks, IoT, and Edge Intelligence. Research Interests: Tactile Internet Mobile Edge Computing Vehicular Networks IoT Edge Intelligence Awards: Nokia Prize for Research Excellence Primetel Awards for Excellence EPSRC and British Council Studentships Publications span cutting-edge topics like adversarial ML attacks on IoT networks, cryptocurrency market analysis, and satellite-backhauled 5G systems. His work bridges theoretical advancements with practical applications in healthcare, agriculture, and transportation systems.

Mhaned OubounytView profile

Researcher

• Single-cell transcriptomics
• Spatial single-cell network analysis
• Gene regulatory networks
• +3 more

Dr. Mhaned Oubounyt is a Postdoctoral Researcher at the University of Hamburg, affiliated with the Computational Systems Biology (CoSy.Bio) group within the Faculty of Mathematics, Informatics and Natural Sciences. His work focuses on developing computational methods for analyzing single-cell and spatial transcriptomics data, particularly in the context of disease mechanisms and drug repurposing. He is actively involved in the NetMap project, advancing dimensionality reduction techniques using differential regulatory networks. Research interests include gene co-expression networks, spatial single-cell analysis, and systems medicine applications. His methodologies bridge computational biology with clinical and agricultural challenges, such as vaccine responses in pregnancy, plant disease resistance, and cardiovascular pathophysiology. Key contributions include the SCANet and Drugst platforms for drug candidate identification and network-based analysis. Publications highlight a strong focus on network biology applications across domains: from immune system modeling to plant stress responses, leveraging single-cell multi-omics integration. His work emphasizes translational research, with implications for personalized medicine and crop improvement. Collaborations span academic and clinical institutions, reflecting his interdisciplinary approach. Current projects aim to enhance predictive modeling of disease progression and therapeutic interventions through systems-level insights.

Mehrdad ArjomandiView profile

Professor

• Environmental Medicine
• Pulmonary Physiology
• Respiratory Disease Mechanisms
• +3 more

Mehrdad Arjomandi, MD, is a Professor of Medicine at the University of California, San Francisco (UCSF), with a joint appointment at the San Francisco VA Health Care System (SFVA). He holds leadership roles as Director of the UCSF Human Exposure Laboratory, Director of the Environmental Medicine Clinic at SFVA, and Director of the SF VA Airborne Hazard Exposure Study Center of Excellence. His research focuses on environmental and occupational exposures contributing to chronic lung diseases, including COPD, asthma, and effects of pollutants like ozone and tobacco smoke. Education: BA in Molecular Biology (UCSD, 1991), MD (Stanford, 1996), Residency in Internal Medicine (UCLA, 1999), Fellowship in Pulmonary & Critical Care (UCSF, 2003). Key Research: Mechanisms of lung injury from airborne hazards, ozone-induced inflammation, and secondhand smoke effects. Studies include SPIROMICS, COPDGene, and VA cohort analyses. Recent work emphasizes cardiopulmonary outcomes in veterans exposed to airborne hazards, machine learning for COPD prognosis, and lung microbiota in COPD. He leads clinical trials evaluating bronchodilators and albuterol efficacy in exposed populations. Grants: Supported by NIH, Flight Attendant Medical Research Institute, VA, and Department of Defense. Awards: 2022 SFVA HeRO Award for clinical excellence and innovation. Labs/Teams: UCSF Human Exposure Lab, SFVA Environmental Medicine Clinic, and VA Airborne Hazard Study Center. Mentors over 30 trainees in translational and clinical research.

Jean-Phillippe CoudercView profile

Professor

• Biomedical Engineering
• Quantitative Electrocardiography
• Ventricular Repolarization Analysis
• +3 more

Dr. Jean-Phillippe Couderc is a Professor in the Department of Medicine (Cardiology) and joint Professor in the Department of Electrical & Computer Engineering at the University of Rochester. He holds a PhD in Biomedical Engineering from the French National Institute of Applied Sciences (1997) and an MBA from the Simon School (2003). His research focuses on quantitative electrocardiography, ventricular repolarization analysis, and cardiac safety analytics. He serves as Chief Technology Officer of iCardiac Technology Inc. and is a member of the editorial board of the Annals of Non-Invasive Electrocardiology . Dr. Couderc has authored/co-authored over 100 publications and holds multiple awards, including the Frost & Sullivan Technology Innovation Award (2006) and the Mirowski-Moss Career Development Award (2003). His work spans computational science, drug safety evaluation, and mHealth technologies for arrhythmia management. He leads federal-funded grants and collaborates with global institutions like the FDA and NIH. Education: PhD, Biomedical Engineering, French National Institute of Applied Sciences (1997) MBA, Simon School of Business (2003) MS, Medical Specialties, France (1994) Key Research Themes: Ventricular repolarization dynamics, ECG signal processing, cardiac safety of non-cardiac drugs, and digital health innovations. Labs/Teams: Heart Research Follow-up Program Laboratory, THEW (Telemetric and Holter ECG Warehouse Initiative).

Berend IsermannView profile

Professor

• Thrombo-inflammation
• Molecular Biology
• Immunology
• +4 more

Professor Berend Isermann is a Professor of Laboratory Medicine at Leipzig University, affiliated with the Faculty of Medicine. He leads research into thrombo-inflammation mechanisms, focusing on molecular pathways linking coagulation and inflammation in diseases such as diabetes, kidney failure, and cardiovascular conditions. His work has earned prestigious recognition, including the ERC Advanced Grant (2024) for a project investigating molecular switches in thrombo-inflammation. Education: Studied medicine at Würzburg (Germany), Bristol (UK), and New Haven (USA). Completed specialist training in internal medicine, endocrinology, and laboratory medicine at Heidelberg University Hospital. Previously held professorships at the Universities of Magdeburg (2011–2019) and Leipzig (2019–present). Research interests center on understanding how thrombo-inflammation drives diseases like preeclampsia, chronic kidney disease, and complications from infections like COVID-19. Key projects include studying tissue factor’s role in inflammation-coagulation cross-talk, microglial-brain interactions in chronic kidney disease, and developing therapies targeting molecular switches. Scientific achievements include discovering tissue factor’s complex with inflammatory regulators, published in high-impact journals, and advancing methods to measure thrombo-inflammatory biomarkers. His interdisciplinary team at Leipzig Medical Center explores therapeutic strategies to control thrombo-inflammation across multiple organ systems. Awards: ERC Advanced Grant (2024) valued at €2.5 million for five years of research into molecular mechanisms of thrombo-inflammation. Grants and collaborations: ERC-funded project involves analyzing molecular switches in heart disease, obesity, and cancer models. His work bridges basic science and clinical translation, with a focus on kidney-brain interactions and diet-based interventions like the green-Mediterranean diet’s epigenetic effects. Labs/Teams: Leads a cross-departmental team at Leipzig University Medical Center integrating immunology, nephrology, and cardiology research. Collaborates on projects involving placental thrombo-inflammation, anticoagulant drug effects, and machine learning applications in diagnostics.

Denise DoolanView profile

Professor

• Molecular Immunology
• Vaccinology
• Infectious Diseases
• +5 more

Professor Denise Doolan is an Affiliate Professor in The University of Queensland's School of Chemistry and Molecular Biosciences and Deputy Director (Research) at the Institute for Molecular Bioscience (IMB). She previously served as Deputy Director of the Australian Institute of Tropical Health and Medicine and Director of the JCU Centre for Molecular Therapeutics. Her research focuses on molecular immunology, vaccine development, and omics-based approaches to combat infectious and chronic diseases, particularly malaria and Epstein-Barr virus (EBV)-related malignancies. She leads cross-disciplinary programs in antigen discovery, host-pathogen immunity, and biomarker development, leveraging genome-based technologies and human disease models. Academic Positions: Affiliate Professor, Deputy Director (IMB), Affiliate of Centre for Superbug Solutions Executive Roles: President of International Society for Vaccines (2021–2023), Member of Australian Medical Research Advisory Board Her research interests include vaccine engineering, systems immunology, and therapeutic development. Key projects involve identifying EBV protein signatures linked to Multiple Sclerosis and malaria immunity profiling using controlled human infection models. She is renowned for her work in malaria immunology and omics-based diagnostics, recognized with Fellowships from the International Society for Vaccines and Australian Society of Parasitology. Recent publications highlight her work on EBV antibody responses in lymphomas, malaria vaccine candidates, and molecular diagnostics for vascular diseases. She actively supervises PhD students in areas like EBV-MS links and malaria systems immunology, supported by grants from NIH, MS Research Australia, and ARC. Scientific Awards: ISV Fellowship (2017), ASP Fellowship (2019) Grants: NIH-funded malaria vaccine projects, EBV-MS diagnostics (MS Research Australia) Her lab collaborates on developing point-of-care tests and next-generation vaccines, emphasizing translational research to address global health challenges.

Mary BarbeView profile

Professor

• Musculoskeletal Disorders
• Neural Plasticity
• Work-Related Injuries
• +7 more

Mary Barbe, PhD, is a Professor at the Lewis Katz School of Medicine at Temple University, with affiliations in multiple research centers: Cardiovascular Sciences, Biomedical Education and Data Science, Neural Sciences, the Center for Substance Abuse Research, and the Comprehensive NeuroAIDS Center. She conducts interdisciplinary research at the intersection of musculoskeletal and neural systems. Her research interests include: Work-related musculoskeletal disorders (WRMDs) and the effects of repetitive and forceful tasks on tissue degeneration and inflammation. Neural plasticity and sensorimotor dysfunction in animal models. Bladder and urethral sphincter reinnervation after spinal cord injury using surgical nerve transfer techniques. Role of fibrosis, inflammation, and aging in bone and connective tissue pathology. Her recent publications show a strong trend in translational research, combining anatomical, physiological, and behavioral assessments in rodent models to understand overuse injuries and neural repair. Her work spans fields such as orthopedics, urology, neuroscience, and rehabilitation science, often involving collaboration with clinical and surgical teams. Her scientific contributions are recognized through consistent publication in high-impact journals, including Journal of Hand Surgery , Neural Plasticity , Life Sciences , and Nature Reviews Urology , with many articles designated as reviews and freely accessible via PMC. Mary Barbe has made significant contributions to mentoring and collaborative research, though specific names of advisees are not listed. She has been continuously funded by major NIH institutes, including NIAMS and NINDS, supporting long-term projects on musculoskeletal injury and neural restoration. She is actively involved in laboratory-based research and collaborates with experts in urology and neuroanatomy. Her lab utilizes advanced techniques such as electrophysiology, neuroanatomical tract tracing, and behavioral assessments to evaluate functional recovery after injury.

Yea-Jen HsuView profile

Academic

• Health Services Research
• Program Evaluation
• Patient Safety
• +7 more

Yea-Jen Hsu is an Associate Research Professor in the Department of Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health. She is actively engaged in health services research with a focus on patient safety, quality improvement, and implementation science. Education: PhD, Johns Hopkins Bloomberg School of Public Health, 2011 MHA, National Yang-Ming University, 2003 BS, National Taiwan University, 2001 Dr. Hsu’s research centers on program evaluation and the application of implementation science to improve healthcare delivery. Her work emphasizes enhancing patient safety culture, reducing healthcare-associated infections, and developing innovative models such as integrating buprenorphine into primary care. She employs rigorous quantitative methods to assess interventions and identify success factors. Her recent publications (2024–2025) reflect a strong focus on patient engagement in pain management, hypertension disparities, infection risk modeling, and electronic health record analytics. These works span high-impact journals in medical quality, internal medicine, and infection control, demonstrating interdisciplinary collaboration and relevance to real-world healthcare systems. Scientific Awards: No awards mentioned in the provided text. Dr. Hsu collaborates extensively with national programs such as the CDC’s Prevention Epicenters and contributes to multi-level interventions aimed at systemic healthcare improvements. While no specific grants or advising roles are listed, her leadership in survey development, data evaluation, and collaborative research indicates active involvement in funded projects. She is not affiliated with a named lab or research team, but her network includes key figures in patient safety and health policy at Johns Hopkins and beyond.

• Microfluidics
• MEMS
• Microfabrication
• +7 more

Mahraz Raveshi is a Research Fellow in the Department of Mechanical & Aerospace Engineering at Monash University, Faculty of Engineering. His work bridges engineering and biomedical sciences, focusing on innovative microscale technologies for reproductive health and cardiovascular modeling. His research interests lie at the intersection of microfluidics, MEMS, micro/nanofabrication, and microscopy, with a particular emphasis on developing lab-on-a-chip systems for biological applications. These include manipulating sperm motility using ultrasound and modeling hemodynamic forces in coronary arteries. Recent publications reveal a strong trend in applying engineering principles to solve clinical challenges, particularly in male infertility and cardiovascular disease. His work combines experimental microdevice fabrication with computational modeling, especially leveraging deep learning for biomedical predictions. Prediction of wall shear stress in coronary bifurcations using deep learning (2025) Ultrasound-based sperm activation and motility maintenance (2024) Microvalve-integrated droplet manipulation chips (2021) Sperm-surface interactions in curved microenvironments (2021) His research has attracted widespread attention, being picked up by over 175 news outlets and shared across multiple social media platforms. He collaborates extensively with experts in bioengineering and reproductive science, including Prof. A. Neild and Dr. R. Nosrati. Mahraz Raveshi advises no publicly listed students but contributes significantly to collaborative research projects. There is no mention of grants in the provided text. He is actively involved in cutting-edge research within Monash’s advanced microfluidics and bioengineering labs, contributing to interdisciplinary teams focused on translating microscale innovations into medical solutions.

Jessica DamoiseauxView profile

Associate Professor

• Cognitive Neuroscience
• Aging
• Neurodegenerative Diseases
• +3 more

Dr. Jessica Damoiseaux is an Associate Professor at Wayne State University, affiliated with the Institute of Gerontology and Department of Psychology. She directs the Ben L. Silberstein Institute for Brain Health and investigates cognitive and brain health changes in aging and neurodegenerative disease. PhD in Cognitive Neuroscience (2008), VU University Medical Center M.Sc. in Psychology (2003), Utrecht University Her research focuses on identifying risk factors for neurodegenerative disease, leveraging MRI to study brain networks, white matter integrity, and structural volumetrics. She explores blood-based biomarkers, genetics, and lifestyle interventions (yoga, exercise) to mitigate cognitive decline. Recent publications (2024–2006) span neuroimaging, aging, Alzheimer's disease, and functional connectivity. Themes include subjective cognitive decline, brain network plasticity, biomarkers, prenatal influences, and multimodal data integration. Collaborations include Dr. Neha Gothe’s exercise trials and interdisciplinary brain network standardization efforts.

• Survival Analysis
• Spatio-Temporal Modeling
• Bayesian Statistics
• +7 more

Maria Antonia Barceló Rado is a Professor at the Department of Economics, University of Girona, and a member of the Research Group on Statistics, Econometrics and Health (GRECS). She is also affiliated with the Centro de Investigación Biomédica en Red en Epidemiología y Salud Pública (CIBERESP) and collaborates with the Centre de Recerca en Economia i Salut (CRES) at Pompeu Fabra University. Her research spans methodological advancements in survival analysis, spatio-temporal modeling, Bayesian statistics , and applied work in clinical epidemiology, environmental epidemiology, cardiovascular risk factors, chronic diseases , and cancer epidemiology . She has developed a mixed-methods line combining Real World Data with Real World Evidence for epidemic prevention and detection. Licenciate in Mathematics (Universitat Autònoma de Barcelona, 1995) PhD in Mathematics (University of Girona, 2001) Accredited as Catedràtica d’Universitat (ANECA, 2018) Her recent publications focus on environmental stressors , air pollution effects , and spatio-temporal modeling across Spain. Articles address mental health in adolescents , vaccination equity , Covid-19 impacts , and chronic disease epidemiology . Collaborations include institutions like Johns Hopkins University, Pompeu Fabra University, and hospitals in Bellvitge and Barcelona.

Sharon-Lise NormandView profile

Professor

• Biostatistics
• Health Services Research
• Medical Device Evaluation
• +7 more

Sharon-Lise Normand is the S. James Adelstein Professor of Health Care Policy (Biostatistics) at Harvard Medical School and Professor of Biostatistics at Harvard T.H. Chan School of Public Health. Her research focuses on statistical methodologies for health services and outcomes research, particularly Bayesian approaches applied to medical device evaluation, causal inference, provider profiling, and evidence synthesis. She leads the Medical Device Epidemiology Network’s Methodology Center and previously directed Mass-DAC, a cardiac surgery quality monitoring initiative. Normand’s work spans cardiovascular disease, severe mental illness, and medical technology diffusion. She has held leadership roles in professional organizations like the American Statistical Association and received multiple awards for her contributions to biostatistics and healthcare research. Dr. Normand holds a PhD from the University of Toronto and completed a postdoctoral fellowship at Harvard Medical School. Her honors include Fellowships in the American Statistical Association, American College of Cardiology, and American Association for the Advancement of Science. She has advised federal agencies such as the FDA and CMS and contributed to policy developments in healthcare quality and equity. Her research team includes experts in biostatistics and data analysis, focusing on topics like telemedicine adoption disparities, racial/ethnic healthcare quality gaps, and the evaluation of medical device safety. Recent work examines pandemic impacts on healthcare access and methodological innovations in causal inference and composite outcome analysis. Normand’s scientific awards reflect her impactful contributions, including the 2017 American Heart Association Lifetime Achievement Award and the 2018 Mosteller Statistician of the Year. She has authored over 200 peer-reviewed publications, with recent studies addressing opioid medication availability, telemedicine trends, and disparities in mental healthcare access under value-based payment models.

Barry DoyleView profile

Adjunct Associate Professor

• Biomedical Engineering
• Cardiovascular Biomechanics
• Computational Fluid Dynamics
• +6 more

Barry Doyle is an Adjunct Associate Professor in the School of Engineering at the University of Western Australia and the Lab Head of the Vascular Engineering Laboratory (VascLab) at the Harry Perkins Institute of Medical Research. He holds a BEng and PhD in Biomedical Engineering from the University of Limerick. His research focuses on cardiovascular health and disease, leveraging cutting-edge engineering techniques, including 3D bioprinting, biomaterials, and computational fluid dynamics. He has secured over $11 million in research funding and co-developed the Biomedical Engineering program at UWA. Notable awards include the Western Australian Innovator of the Year (2021) and three Mimics Innovation Awards (2009, 2017, 2018). Education: BEng (2005), PhD (2009), both in Biomedical Engineering, University of Limerick. Affiliations: Honorary Fellow at the British Heart Foundation Centre, University of Edinburgh; CTO at FloMatrix. His research interests span cardiovascular biomechanics, soft tissue modeling, and medical device development. He has authored over 140 publications and edited several textbooks, including Cardiovascular Biomechanics (Springer, 2017). His work addresses diseases like aortic aneurysms, coronary artery disease, and placental vascular dysfunction. His lab, VascLab, focuses on translating engineering innovations into clinical applications, such as novel heart valves and vascular implants. He has led projects funded by NHMRC, ARC, and industry partners. Awards: Western Australian Innovator of the Year 2021 UHU Seed Funding Grant 2019 Three Mimics Innovation Awards Grants & Funding: Over $11M as lead/co-lead in projects like the ARC Training Centre for Personalised Therapeutics Technologies. Doyle is an active editor for journals such as Medical Engineering & Physics and European Journal of Vascular and Endovascular Surgery , and a reviewer for national/international funding bodies.

• Geriatric Cardiology
• Cardiac Amyloidosis
• Frailty in Aging
• +4 more

Elyn Montgomery is a Lecturer in the School of Nursing and Midwifery at the University of Technology Sydney (UTS), part of the Faculty of Health. Her research focuses on frailty in older adults, particularly its intersection with cardiovascular diseases such as cardiac amyloidosis and heart failure. She explores how frailty impacts clinical outcomes in high-risk populations, including those undergoing mechanical circulatory support or transplantation. Her work integrates geriatric cardiology, critical care nursing, and translational research to improve patient management strategies. Key areas include frailty assessment tools, multidisciplinary care models, and prognostic indicators in cardiac and pulmonary transplantation. Montgomery’s publications from 2022–2025 reflect a strong emphasis on translational research, bridging basic science and clinical practice. Her studies often involve collaborative teams from cardiology, geriatrics, and allied health disciplines.